VintherJLJacobsenRKJorgensenT. Current European guidelines for management of cardiovascular disease: Is medical treatment in nearly half a population realistic?Eur J Prev Cardiol2018; 25: 157–163.
2.
BerkelmansGFVisserenFLJaspersNEet al.SPRINT trial: It’s not just the blood pressure!. Eur J Prev Cardiol2017; 24: 1482–1484.
3.
YangWYZhangZYThijsLet al.Left ventricular function in relation to chronic residential air pollution in a general population. Eur J Prev Cardiol2017; 24: 1416–1428.
4.
MannucciPM. Air pollution levels and cardiovascular health: Low is not enough. Eur J Prev Cardiol2017; 24: 1851–1853.
5.
VidaleSCampanaC. Ambient air pollution and cardiovascular diseases: From bench to bedside. Eur J Prev Cardiol2018; 25: 818–825.
6.
BakhtiyariMSchmidtNHadaeghFet al.Direct and indirect effects of central and general adiposity on cardiovascular diseases: The Tehran Lipid and Glucose Study. Eur J Prev Cardiol2018; 25: 1170–1181.
7.
GroenhofTKJvan RijnBBFranxAet al.Preventing cardiovascular disease after hypertensive disorders of pregnancy: Searching for the how and when. Eur J Prev Cardiol2017; 24: 1735–1745.
8.
GlisicMShahzadSTsoliSet al.Association between progestin-only contraceptive use and cardiometabolic outcomes: A systematic review and meta-analysis. Eur J Prev Cardiol2018; 25: 1042–1052.
9.
KievitRFGoharAHoesAWet al.Efficient selective screening for heart failure in elderly men and women from the community: A diagnostic individual participant data meta-analysis. Eur J Prev Cardiol2018; 25: 437–446.
10.
De WaardA-KMWandellPEHolzmannMJet al.Barriers and facilitators to participation in a health check for cardiometabolic diseases in primary care: A systematic review. Eur J Prev Cardiol2018; 25: 1326–1340.
NorlundFLissåkerCWallertJet al.Factors associated with emotional distress in patients with myocardial infarction: Results from the SWEDEHEART registry. Eur J Prev Cardiol2018; 25: 910–920.
13.
KotsevaKWoodDde BacquerD. EUROASPIRE investigators. Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey. Eur J Prev Cardiol2018; 25: 1242–1251.
14.
SharmaSPapatheodorouE. Twelve-lead ECG monitoring in athletes: Positive strides on the master athlete's track. Eur J Prev Cardiol2018; 25: 2000–2002.
15.
ZorziAMastellaGCiprianiAet al.Burden of ventricular arrhythmias at 12-lead 24-hour ambulatory ECG monitoring in middle-aged endurance athletes versus sedentary controls. Eur J Prev Cardiol2018; 25: 2003–2011.
16.
GrazioliGSanz de la GarzaMVidalBet al.Prevention of sudden death in adolescent athletes: Incremental diagnostic value and cost-effectiveness of diagnostic tests. Eur J Prev Cardiol2017; 24: 1446–1454.
17.
MontLPellicciaASharmaSet al.Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. Eur J Prev Cardiol2017; 24: 41–69.
